James Schaub
Chief Operating Officer bei RVL PHARMACEUTICALS PLC
Vermögen: - $ am 31.03.2024
Profil
James Schaub is currently the Chief Operating Officer & Executive Vice President at RVL Pharmaceuticals Plc since 2016.
Prior to this, he worked as the Vice President-Mergers & Acquisitions at Fougera Pharmaceuticals, Inc. from 2011 to 2012.
He also served as the Chief Operating Officer at Trigen Laboratories LLC.
Mr. Schaub completed his undergraduate degree from Middlebury College and earned an MBA from Rutgers Business School.
Bekannte Unternehmensbeteiligungen
| Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
|---|---|---|---|---|
RVL PHARMACEUTICALS PLC
0,45% | 10.11.2023 | 506 521 ( 0,45% ) | - $ | 31.03.2024 |
Aktive Positionen von James Schaub
| Unternehmen | Position | Beginn |
|---|---|---|
| RVL PHARMACEUTICALS PLC | Chief Operating Officer | 01.01.2016 |
Ehemalige bekannte Positionen von James Schaub
| Unternehmen | Position | Ende |
|---|---|---|
Fougera Pharmaceuticals, Inc.
 Fougera Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Fougera Pharmaceuticals, Inc. develops and manufactures specialty pharmaceuticals in dermatology. It operates through two core divisions: PharmaDerm and Fougera. The PharmaDerm division offers in-house expertise and facilities for formulation development, clinical development, manufacturing, distribution, and sales and marketing. The company was founded in 1849 and is headquartered in Melville, NY. | Corporate Officer/Principal | 01.09.2012 |
Trigen Laboratories LLC
 Trigen Laboratories LLC Drugstore ChainsRetail Trade Part of Vertical/Trigen Holdings LLC, Trigen Laboratories LLC is a generic pharmaceutical company that provides generic solutions for dietary supplements, drugs, medical devices, and more. The private company is based in Sayreville, NJ. Leveraging a network of internal and external partners, Trigen aims to develop a wide-range portfolio of generic pharmaceutical products. The company offers affordable access to quality healthcare for their customers and provide generic products that meet a wide array of practical healthcare applications. | Chief Operating Officer | - |
Ausbildung von James Schaub
| Middlebury College | Undergraduate Degree |
| Rutgers Business School | Masters Business Admin |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Börsennotierte Unternehmen | 1 |
|---|---|
| RVL PHARMACEUTICALS PLC | Health Technology |
| Private Unternehmen | 2 |
|---|---|
Fougera Pharmaceuticals, Inc.
Fougera Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Fougera Pharmaceuticals, Inc. develops and manufactures specialty pharmaceuticals in dermatology. It operates through two core divisions: PharmaDerm and Fougera. The PharmaDerm division offers in-house expertise and facilities for formulation development, clinical development, manufacturing, distribution, and sales and marketing. The company was founded in 1849 and is headquartered in Melville, NY. | Health Technology |
Trigen Laboratories LLC
Trigen Laboratories LLC Drugstore ChainsRetail Trade Part of Vertical/Trigen Holdings LLC, Trigen Laboratories LLC is a generic pharmaceutical company that provides generic solutions for dietary supplements, drugs, medical devices, and more. The private company is based in Sayreville, NJ. Leveraging a network of internal and external partners, Trigen aims to develop a wide-range portfolio of generic pharmaceutical products. The company offers affordable access to quality healthcare for their customers and provide generic products that meet a wide array of practical healthcare applications. | Retail Trade |
